FDA clearance positions SMILE Dx as a pioneering AI-powered platform for early detection and diagnosis in dental care, streamlining clinical workflows and improving patient outcomes.
Revolutionary platform integrates augmented reality and artificial intelligence to enhance surgical training and anatomical education globally
University of Alberta researchers have created a new tool to help doctors and patients recognize other illnesses commonly associated with inflammatory bowel disease (IBD), including autoimmune, mental health and heart problems.
New technology isolates extracellular vesicles from blood to enable earlier, non-invasive disease detection and personalized treatment strategies.
Next-gen portable ultrasound system combines speed, image clarity, and AI-powered tools to elevate diagnostic confidence at the bedside.
Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called “Fragle” that makes tracking cancer easier and faster using blood tests.
New leadership and AI-driven technology aim to revolutionize assessment and care for brain-related conditions
Olympus announced today that it has fully launched its AI-driven emphysema screening program, SeleCT Screening.
Regulatory Milestone Validates JBA AI’s Clinical-Grade Software for Advanced Diagnostic Support
New AI-driven software delivers unprecedented image quality improvements, enhancing diagnostic accuracy and expanding the capabilities of portable MRI technology.